On July 21-22, 2026, President Donald Trump unveiled a phased tariff plan on imported generic drugs, targeting the reshoring of pharmaceutical manufacturing to the United States. The announcement sent shockwaves…
Bioequivalence is the scientific foundation that makes generic medicines interchangeable with their brand-name counterparts. For international buyers considering Indian generic medicines, understanding how bioequivalence is established, verified, and regulated is…
The ongoing Iran war and the disruption of shipping through the Strait of Hormuz have triggered one of the most significant shocks to global pharmaceutical supply chains in decades. For…
India has earned its reputation as the "Pharmacy of the World" by producing high-quality generic medicines at a fraction of the cost charged in developed countries. For international buyers —…